Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.
मुख्य लेखकों: | MacMahon, S, Rodgers, A, Collins, R, Farrell, B |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
1994
|
समान संसाधन
-
ANTIPLATELET THERAPY TO PREVENT THROMBOSIS AFTER HIP FRACTURE - REPLY
द्वारा: Macmahon, S, और अन्य
प्रकाशित: (1995) -
The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
द्वारा: Prentice, C, और अन्य
प्रकाशित: (1999) -
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
द्वारा: Kyung Won Kim, और अन्य
प्रकाशित: (2021-01-01) -
Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
द्वारा: Collins, R, और अन्य
प्रकाशित: (1994) -
A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial
द्वारा: de Haan RJ, और अन्य
प्रकाशित: (2010-05-01)